On Track to File IND Application for STAR-0215 Mid-Year Initial Phase 1a Clinical Results Anticipated by Year End 2022 BOSTON (BUSINESS WIRE) Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company developing STAR-0215 for hereditary angioedema (HAE) and focused on life-changing therapies fo.
Perceptive Advisors closes $515M fund to fuel more early-stage biotech startups
Perceptive Advisors closes $515M fund to fuel more early-stage biotech startups
Perceptive Advisors has $515 million for its second fund investing in biotech startups. Portfolio Manager Chris Garabedian says Perceptive Xontogeny Ventures Fund II is looking to make Series A investments in early-stage companies with assets that can show a path to clinical testing.
Shares0
When Chris Garabedian set out early last year to raise money for a second Perceptive Advisors fund focused on early-stage biotech startups, it took just a matter of months to draw interest from investors willing to commit more than $1 billion total. The fund could have closed with that much money, maybe more, said Garabedian, the portfolio manager. But it ended up with a little more than half of that, which he described as “the right size.”
Xontogeny Announces Launch of Several New Early-Stage Portfolio Companies streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
88 Biggest Movers From Friday Benzinga 2/1/2021
Gainers
Siebert Financial Corp. (NASDAQ: SIEB) shares climbed 121.6% to close at $8.22 on Friday on heavy volume.
Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB) climbed 70.8% to close at $4.15 after the company announced the acquisition of Quellis Biosciences.
GameStop Corp. (NYSE: GME) shares added 67.9% to close at $325.00 after Robinhood said it would allow some buying of the stocks on Friday after sparking outrage over discontinuing purchases of GME, AMC, and high stocks seeing social media interest. The company’s stock dropped over 44% on Thursday.
Novavax, Inc. (NASDAQ: NVAX) surged 64.9% to close at $220.94 after the company said Thursday that its COVID-19 vaccine candidate NVX-COV2373 showed 89.3% efficacy in Phase 3 trials conducted in the United Kingdom.
Shares of Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB) got a boost, shooting 130% to $5.59 after the company announced the acquisition of Quellis Biosciences.
GameStop Corp. (NYSE: GME) shares were also up, gaining 74% to $337.03 after Robinhood said it would allow some buying of the stocks on Friday after sparking outrage over discontinuing purchases of GME, AMC, and high stocks seeing social media interest. The company’s stock dropped over 44% on Thursday.
Equities Trading DOWN
Drive Shack Inc. (NASDAQ: DS) shares tumbled 20% to $2.525 after the company announced a common stock offering of 20.83 million shares at $2.40 per share.
Shares of Ucommune International Ltd (NASDAQ: UK) were down 31% to $3.5250 after the company reported pricing of $20 million underwritten offering.